-
Mashup Score: 1Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR) - 26 day(s) ago
ABSTRACTIntroduction. Despite extensive studies of the impact of COVID-19 on patients with cancer, there is a dearth of information from the Middle East and North Africa (MENA) region. Our study aimed to report pertinent MENA COVID-19 and Cancer Registry (MCCR) findings on patient management and outcomes.Methods. MCCR was adapted from the American Society of Clinical Oncology COVID-19 Registry to collect data specifically from patients with cancer and SARS-CoV-2 infection from 12 centers in eight countries including Saudi Arabia, Jordan, Lebanon, Turkey, Egypt, Algeria, United Arab Emirates, and Morocco. The Registry included data on patients and disease characteristics, treatment, and patient outcomes. Logistic regression was used to assess associations with mortality.Results. Between November 29, 2020, and June 8, 2021, data were captured on 2008 patients diagnosed with COVID-19 from the beginning of the pandemic. Median age was 56 years (16–98), 56.4% were females, and 26% were curr
Source: meridian.allenpress.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11Quality Measures for Multidisciplinary Tumor Boards and Their Role in Improving Cancer Care - 4 month(s) ago
ABSTRACTIntroduction. While multidisciplinary tumor boards (MTBs) are widely used in managing patients with cancer, their impact on patient care and outcome is not routinely measured in different settings.Methods. The authors conducted a literature review in Medline, Google Scholar, Embase, and Web of Science using the following keywords: cancer, multidisciplinary, tumor board, quality performance indicator, lung cancer, and lymphoma. Standards from various accreditation and professional organizations were reviewed to compile relevant standards for MTB.Results. A list of quality performance indicators that can be used to improve MTBs’ performance and impact was compiled. Specific examples for non-Hodgkin lymphoma and lung cancer MTBs were presented. Guidance was provided to help MTB team members select implement the appropriate quality measures.Conclusion. The functions and impact of MTBs should be monitored and evaluated by a set of measures that help guide MTBs to improve their perfo
Source: meridian.allenpress.comCategories: General Medicine News, Hem/OncsTweet-
#tumor #board is a critical component of #cancercare. To optimize the #quality of these boards, we need #measures. In this review article, we reviewed some of these measures. @OncologyNetwork @JQSHEditors @JIPOEditors #cancer #qualityimprovement https://t.co/jisjHVoQOU
-
-
Mashup Score: 11Quality Measures for Multidisciplinary Tumor Boards and Their Role in Improving Cancer Care - 4 month(s) ago
ABSTRACTIntroduction. While multidisciplinary tumor boards (MTBs) are widely used in managing patients with cancer, their impact on patient care and outcome is not routinely measured in different settings.Methods. The authors conducted a literature review in Medline, Google Scholar, Embase, and Web of Science using the following keywords: cancer, multidisciplinary, tumor board, quality performance indicator, lung cancer, and lymphoma. Standards from various accreditation and professional organizations were reviewed to compile relevant standards for MTB.Results. A list of quality performance indicators that can be used to improve MTBs’ performance and impact was compiled. Specific examples for non-Hodgkin lymphoma and lung cancer MTBs were presented. Guidance was provided to help MTB team members select implement the appropriate quality measures.Conclusion. The functions and impact of MTBs should be monitored and evaluated by a set of measures that help guide MTBs to improve their perfo
Source: meridian.allenpress.comCategories: General Medicine News, Hem/OncsTweet-
#tumor #board is a critical component of #cancercare. To optimize the #quality of these boards, we need #measures. In this review article, we reviewed some of these measures. @OncologyNetwork @JQSHEditors @JIPOEditors #cancer #qualityimprovement https://t.co/jisjHVoQOU
-
-
Mashup Score: 2
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
Source: connection.asco.orgCategories: General Medicine News, Hem/OncsTweet-
The use of dietary supplements is very common among #patients with #cancer, yet it is not fully addressed by #oncologists. We need a fresh serious look at this matter! @ASCO @ASCOPost @OncoAlert @OncLive @OncologyNetwork @CancerAdvisors https://t.co/2cvcgxIn15
-
-
Mashup Score: 0Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision? - 7 month(s) ago
Precision medicine for cancer is rapidly moving to an approach that integrates multiple dimensions of the biology in order to model mechanisms of cancer progression in each patient. The discovery of multiple drivers per tumor challenges medical decision that faces several treatment options. Drug sensitivity depends on the actionability of the target, its clonal or subclonal origin and coexisting genomic alterations. Sequencing has revealed a large diversity of drivers emerging at treatment failure, which are potential targets for clinical trials or drug repurposing.
Source: www.esmoopen.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Useful nice reading! @OncologyNetwork @JIPOEditors #oncology #cancer https://t.co/rYO6F33ZKm
-
-
Mashup Score: 0The principles of oncology care: back to basics - PubMed - 9 month(s) ago
The principles of oncology care: back to basics
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet-
@AaronGoodman33 @csoncol https://t.co/8faH4lXxFA
-
-
Mashup Score: 4AHIS 2023 - Abstract Submission Form - 9 month(s) ago
Please click the link to complete this form.
Source: form.jotform.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Do you have an innovative idea or project you like to share with others. Submit an abstract to AHIS 2023. #innovation #healthcareinnovation #healthcare @ZKozlakidis @EditorsIddb @Innovativehci @OncologyNetwork https://t.co/GB5IWL28P3 https://t.co/HwiWNKvBnH
-
-
Mashup Score: 0Taking Back Sunday - 9 month(s) ago
1 Department of Medicine, Intermountain Medical Center, Intermountain Health, Murray, UT, USA This content is only available as a PDF. Source of Support: None. Conflict of Interest: None. Lewis MA. Taking back Sunday. This work is published under a CC-BY-NC-ND 4.0 International License. This site uses cookies. By continuing to use our website, you are agreeing to our privacy
Source: meridian.allenpress.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Taking Back Sunday https://t.co/uf6Wxff3Xk @OncoAlert @OncLive @JIPOEditors @JQSHEditors #burnout
-
-
Mashup Score: 3Caring for Caregivers: An Overdue Need for Effective Intervention - 9 month(s) ago
Caregiver support is fragmented and inadequate. Here are 7 steps oncology professionals can take to address this urgent need.
Source: connection.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Caring for Caregivers: An Overdue Need for Effective Intervention | ASCO Connection @ASCO @myESMO @OncoAlert @ConquerCancerFd @CancerAdvisors @OncologyNetwork https://t.co/PBGWDFdCiy
-
-
Mashup Score: 0The Medical Minute - Ep. #73 - ASCO Direct™: A Patient Perspective FT. Dr. Alex Adjei - 10 month(s) ago
CCA’s Steve Abbott and Dr. Abdul Jazieh welcome Dr. Alex Adjei to discuss the overall survival analysis from the ADAURA trial of adjuvant osimertinib in pati…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
Discussion of ADAURA update presented at #ASCO23 with Dr @DrAlexAdjei @CancerAdvisors @ASCO @ConquerCancerFd @OncologyNetwork @OncoAlert https://t.co/L02LJ2tXS2
-
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR) https://t.co/DTYQf9XucE